Literature DB >> 2339848

Experimental pulmonary eosinophilia in mice by Ascaris suum extract.

M Nogami1, M Suko, H Okudaira, T Miyamoto, J Shiga, M Ito, S Kasuya.   

Abstract

The transnasal administration of an extract of the parasite Ascaris suum (Asc) to C57BL/6 mice for 3 wk produced marked eosinophilia in the bronchoalveolar lavage (BAL) fluid. This pulmonary eosinophilia was not accompanied by blood eosinophilia. The oral administration of cyclosporin, 50 mg/kg body weight, every other day significantly suppressed the pulmonary eosinophilia. Athymic C57BL/6-nu/nu mice failed to develop pulmonary eosinophilia. These data indicate that pulmonary eosinophilia caused by this parasite extract is T-cell-dependent. Genetically mast-cell-deficient (WB X C57BL/6)F1-W/WV (W/WV) mice developed marked eosinophilia in the BAL, which shows that mast cells are not necessary in the formation of eosinophilia in BAL in this model. C57BL/6, W/WV, and Balb-C mice that developed eosinophilia in the BAL also showed elevated total IgE levels and IgE titers against Asc in the sera. On the other hand, C57BL/6-nu/nu mice and IgE low-responder SJL mice, which developed little eosinophilia, did not show elevated total IgE levels and IgE titers against Asc in the sera. However, oral administration of cyclosporin, 50 mg/kg, which inhibited eosinophilia in the BAL in C57BL/6 mice, did not significantly inhibit the elevation of total IgE or IgE against Asc in the sera. This indicates that serum IgE production is not required for the formation of eosinophilia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2339848     DOI: 10.1164/ajrccm/141.5_Pt_1.1289

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  11 in total

Review 1.  Approaches for analyzing the roles of mast cells and their proteases in vivo.

Authors:  Stephen J Galli; Mindy Tsai; Thomas Marichal; Elena Tchougounova; Laurent L Reber; Gunnar Pejler
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

Review 2.  Potential effector and immunoregulatory functions of mast cells in mucosal immunity.

Authors:  L L Reber; R Sibilano; K Mukai; S J Galli
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

Review 3.  Complexity and redundancy in the pathogenesis of asthma: reassessing the roles of mast cells and T cells.

Authors:  S J Galli
Journal:  J Exp Med       Date:  1997-08-04       Impact factor: 14.307

4.  The effect of the neurokinin antagonist FK-224 on the cough response to inhaled capsaicin in a new model of guinea-pig eosinophilic bronchitis induced by intranasal polymyxin B.

Authors:  H Ogawa; M Fujimura; M Saito; T Matsuda; N Akao; K Kondo
Journal:  Clin Auton Res       Date:  1994-04       Impact factor: 4.435

5.  A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia.

Authors:  Shigeki Katoh; Nobuhiro Matsumoto; Kumiko Kawakita; Akira Tominaga; Paul W Kincade; Shigeru Matsukura
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

6.  Cyclosporin A increases the pulmonary eosinophilia induced by inhaled Aspergillus antigen in mice.

Authors:  J M Wang; M Denis; M Fournier; M Laviolette
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

7.  Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice.

Authors:  C M Williams; S J Galli
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

8.  Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice.

Authors:  K Takeda; E Hamelmann; A Joetham; L D Shultz; G L Larsen; C G Irvin; E W Gelfand
Journal:  J Exp Med       Date:  1997-08-04       Impact factor: 14.307

Review 9.  Mast Cells and Their Progenitors in Allergic Asthma.

Authors:  Erika Méndez-Enríquez; Jenny Hallgren
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

10.  Mast cells and the development of allergic airway disease.

Authors:  Sebastian Reuter; Christian Taube
Journal:  J Occup Med Toxicol       Date:  2008-02-27       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.